Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real-life study (DUPIREAL).
De Corso E, Pasquini E, Trimarchi M, La Mantia I, Pagella F, Ottaviano G, Garzaro M, Pipolo C, Torretta S, Seccia V, Cantone E, Ciofalo A, Lucidi D, Fadda GL, Pafundi PC, Settimi S, Montuori C, Anastasi F, Pagliuca G, Ghidini A, Cavaliere C, Maffei M, Bussu F, Gallo S, Canevari FRM, Paludetti G, Galli J; Dupireal Italian Study Group. De Corso E, et al. Among authors: ciofalo a. Allergy. 2023 Oct;78(10):2669-2683. doi: 10.1111/all.15772. Epub 2023 May 26. Allergy. 2023. PMID: 37203259
Local treatment of aspecific nasal hyperreactivity with capsaicin.
Filiaci F, Zambetti G, Ciofalo A, Luce M, Masieri S, Lovecchio A. Filiaci F, et al. Among authors: ciofalo a. Allergol Immunopathol (Madr). 1994 Nov-Dec;22(6):264-8. Allergol Immunopathol (Madr). 1994. PMID: 7892815 Clinical Trial.
Screening patients affected by common variable immunodeficiency.
Masieri S, Orlando MP, Ciofalo A, Luzi G, Zambetti C, Filiaci F. Masieri S, et al. Among authors: ciofalo a. Ann N Y Acad Sci. 1997 Dec 29;830:322-5. doi: 10.1111/j.1749-6632.1997.tb51904.x. Ann N Y Acad Sci. 1997. PMID: 9616692
Pleasantness of olfactory and trigeminal stimulants in different Italian regions.
Cantone E, Ciofalo A, Vodicka J, Iacono V, Mylonakis I, Scarpa B, Russo M, Iengo M, de Vincentiis M, Martini A, Ottaviano G. Cantone E, et al. Among authors: ciofalo a. Eur Arch Otorhinolaryngol. 2017 Nov;274(11):3907-3913. doi: 10.1007/s00405-017-4722-5. Epub 2017 Aug 31. Eur Arch Otorhinolaryngol. 2017. PMID: 28861603
Long-term omalizumab efficacy in allergic rhinitis.
Cavaliere C, Begvarfaj E, Incorvaia C, Sposato B, Brunori M, Ciofalo A, Greco A, de Vincentiis M, Masieri S. Cavaliere C, et al. Among authors: ciofalo a. Immunol Lett. 2020 Nov;227:81-87. doi: 10.1016/j.imlet.2020.08.002. Epub 2020 Aug 13. Immunol Lett. 2020. PMID: 32798500 Free article.
The safety of sublingual immunotherapy, can the rare systemic reactions be prevented?
Cavaliere C, Incorvaia C, Begvarfaj E, Orlando MP, Turchetta R, Musacchio A, Ralli M, Ciofalo A, Greco A, de Vincentiis M, Masieri S. Cavaliere C, et al. Among authors: ciofalo a. Expert Opin Drug Saf. 2021 Mar;20(3):259-264. doi: 10.1080/14740338.2021.1874917. Epub 2021 Jan 21. Expert Opin Drug Saf. 2021. PMID: 33427529
65 results